143 related articles for article (PubMed ID: 35534339)
1. Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy.
Toyoda H; Yasuda S; Moriya A; Itobayashi E; Uojima H; Watanabe T; Atsukawa M; Arai T; Ishikawa T; Mikami S; Hiraoka A; Tsuji K; Oikawa T; Tsubota A; Nozaki A; Chuma M; Abe H; Shima T; Kumada T; Tanaka J
J Infect Chemother; 2022 Sep; 28(9):1231-1234. PubMed ID: 35534339
[TBL] [Abstract][Full Text] [Related]
2. Lack of hepatitis C virus reinfection in lifetime of Japanese general population with previous hepatitis C virus (HCV) infection successfully treated with anti-HCV therapy.
Toyoda H; Yasuda S; Shiota S; Kumada T; Tanaka J
J Infect Chemother; 2021 Nov; 27(11):1674-1675. PubMed ID: 34419353
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
[TBL] [Abstract][Full Text] [Related]
4. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
5. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
[TBL] [Abstract][Full Text] [Related]
6. Biopsy Specimens From Allograft Liver Contain Histologic Features of Hepatitis C Virus Infection After Virus Eradication.
Whitcomb E; Choi WT; Jerome KR; Cook L; Landis C; Ahn J; Te HS; Esfeh J; Hanouneh IA; Rayhill SC; Gibson W; Plesec T; Koo J; Wang HL; Hart J; Pai RK; Westerhoff M
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1279-1285. PubMed ID: 28501538
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents.
Yousif MM; Elsadek Fakhr A; Morad EA; Kelani H; Hamed EF; Elsadek HM; Zahran MH; Fahmy Afify A; Ismail WA; Elagrody AI; Ibrahim NF; Amer FA; Zaki AM; Sadek AMEM; Shendi AM; Emad G; Farrag HA
Infez Med; 2018 Sep; 26(3):237-243. PubMed ID: 30246766
[TBL] [Abstract][Full Text] [Related]
8. Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response.
Khattab MA; Zakaria Y; Sadek E; Abd El Fatah AS; Fouad M; Khattab M; Moness HM; Adel NM; Ahmed E
Clin Exp Med; 2023 Feb; 23(1):131-140. PubMed ID: 35066710
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B.
Toyoda H; Kumada T; Tada T; Shimada N; Takaguchi K; Senoh T; Tsuji K; Tachi Y; Hiraoka A; Ishikawa T; Shima T; Okanoue T
J Hepatol; 2017 Mar; 66(3):521-527. PubMed ID: 27890790
[TBL] [Abstract][Full Text] [Related]
10. Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
Aebi-Popp K; Wandeler G; Salazar-Vizcaya L; Metzner K; Stöckle M; Cavassini M; Hoffmann M; Lüthi A; Suter F; Bernasconi E; Fehr J; Furrer H; Rauch A;
HIV Med; 2018 Jul; 19(6):420-425. PubMed ID: 29573533
[TBL] [Abstract][Full Text] [Related]
11. Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International Cohort Studies.
Asselah T; Esmat G; Sanai FM; Goulis I; Messinger D; Bakalos G; Waked I
Adv Ther; 2016 Oct; 33(10):1797-1813. PubMed ID: 27517563
[TBL] [Abstract][Full Text] [Related]
12. Current elimination status of hepatitis C virus-infected maintenance hemodialysis patients in Iwate Prefecture, Japan.
Miyasaka A; Yoshida Y; Suzuki A; Endo K; Kakisaka K; Oikawa T; Abe T; Obara W; Matsumoto T
Ther Apher Dial; 2023 Oct; 27(5):848-854. PubMed ID: 37125473
[TBL] [Abstract][Full Text] [Related]
13. Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.
Toyoda H; Tada T; Takaguchi K; Senoh T; Shimada N; Hiraoka A; Michitaka K; Ishikawa T; Kumada T
J Viral Hepat; 2017 Jun; 24(6):472-476. PubMed ID: 27983762
[TBL] [Abstract][Full Text] [Related]
14. Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
Liver Int; 2016 Jun; 36(6):817-26. PubMed ID: 26787002
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis.
Kumada T; Toyoda H; Yasuda S; Tada T; Ito T; Tanaka J
J Viral Hepat; 2021 Sep; 28(9):1293-1303. PubMed ID: 34185932
[TBL] [Abstract][Full Text] [Related]
16. Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.
Simmons B; Saleem J; Hill A; Riley RD; Cooke GS
Clin Infect Dis; 2016 Mar; 62(6):683-694. PubMed ID: 26787172
[TBL] [Abstract][Full Text] [Related]
17. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
18. Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients.
Campos-Varela I; Castells L; Esteban JI; Bes M; Rodríguez-Frías F; Sapisochin G; Allende H; Charco R; Esteban R
Transplantation; 2012 Feb; 93(4):450-3. PubMed ID: 22262129
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.
Seko Y; Moriguchi M; Takahashi A; Yamaguchi K; Umemura A; Okuda K; Kataoka S; Unozawa H; Kobayashi K; Ogasawara S; Sato R; Tsuchiya S; Watanabe S; Morimoto N; Iwai K; Aramaki T; Kato N; Itoh Y
J Gastroenterol; 2022 Feb; 57(2):90-98. PubMed ID: 35031857
[TBL] [Abstract][Full Text] [Related]
20. Eradication of hepatitis C virus infection in kidney transplant recipients using direct-acting antiviral therapy: Qatar experience.
Alkadi MM; Abuhelaiqa EA; Elshirbeny MF; Hamdi AF; Fituri OM; Asim M; Alkaabi SR; Derbala MF; Jarman ME; Ashour AM; Nauman A; Al Maslamani YK; Butt AA; Al-Malki HA
Immun Inflamm Dis; 2021 Mar; 9(1):246-254. PubMed ID: 33264509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
